A citation-based method for searching scientific literature

Junichi Ishigami, Marco Trevisan, Lars H Lund, Tomas Jernberg, Josef Coresh, Kunihiro Matsushita, Juan-Jesus Carrero. Eur J Heart Fail 2020
Times Cited: 11







List of co-cited articles
51 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.
Claudio Ronco, Peter McCullough, Stefan D Anker, Inder Anand, Nadia Aspromonte, Sean M Bagshaw, Rinaldo Bellomo, Tomas Berl, Ilona Bobek, Dinna N Cruz,[...]. Eur Heart J 2010
563
36

Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
36

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph,[...]. N Engl J Med 2020
520
36

A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
27

Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome.
Junichi Ishigami, Logan T Cowan, Ryan T Demmer, Morgan E Grams, Pamela L Lutsey, Juan-Jesus Carrero, Josef Coresh, Kunihiro Matsushita. J Am Soc Nephrol 2020
22
27

The kidney in heart failure: an update.
Kevin Damman, Jeffrey M Testani. Eur Heart J 2015
261
27

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
27

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
27

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.
Morgan E Grams, Yingying Sang, Shoshana H Ballew, Kunihiro Matsushita, Brad C Astor, Juan Jesus Carrero, Alex R Chang, Lesley A Inker, Timothy Kenealy, Csaba P Kovesdy,[...]. J Am Soc Nephrol 2019
65
18

Nutritional status in tricuspid regurgitation: implications of transcatheter repair.
Christian Besler, Matthias Unterhuber, Karl-Philipp Rommel, Elisabeth Unger, Philipp Hartung, Maximilian von Roeder, Thilo Noack, Markus Zachäus, Ulrich Halm, Michael Borger,[...]. Eur J Heart Fail 2020
19
18

Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).
Christiane E Angermann, Birgit Assmus, Stefan D Anker, Folkert W Asselbergs, Johannes Brachmann, Marie-Elena Brett, Jasper J Brugts, Georg Ertl, Greg Ginn, Lutz Hilker,[...]. Eur J Heart Fail 2020
75
18

Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
Petar M Seferovic, Piotr Ponikowski, Stefan D Anker, Johann Bauersachs, Ovidiu Chioncel, John G F Cleland, Rudolf A de Boer, Heinz Drexel, Tuvia Ben Gal, Loreena Hill,[...]. Eur J Heart Fail 2019
355
18

Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?
Michele Senni, Marianna Adamo, Marco Metra, Ottavio Alfieri, Alec Vahanian. Eur J Heart Fail 2019
69
18

Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
Christian Nitsche, Stefan Aschauer, Andreas A Kammerlander, Matthias Schneider, Thomas Poschner, Franz Duca, Christina Binder, Matthias Koschutnik, Julian Stiftinger, Georg Goliasch,[...]. Eur J Heart Fail 2020
52
18

Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis.
David Messika-Zeitoun, Patrick Verta, John Gregson, Stuart J Pocock, Isabel Boero, Ted E Feldman, William T Abraham, JoAnn Lindenfeld, Jeroen Bax, Martin Leon,[...]. Eur J Heart Fail 2020
41
18

Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study.
Wilfried Mullens, Faisal Sharif, Matthias Dupont, Alexander M K Rothman, William Wijns. Eur J Heart Fail 2020
25
18

Clinical course after a first episode of heart failure: insights from the Framingham Heart Study.
Raghava S Velagaleti, Martin G Larson, Danielle Enserro, Rebecca J Song, Ramachandran S Vasan. Eur J Heart Fail 2020
5
40

Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries.
Shmuel Chen, Bjorn Redfors, Aaron Crowley, Ori Ben-Yehuda, Matthew Summers, Rebecca T Hahn, Wael A Jaber, Philippe Pibarot, Maria C Alu, Katherine H Chau,[...]. Eur J Heart Fail 2020
12
18

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP-HF study.
Dirk J van Veldhuisen, Gijs van Woerden, Thomas M Gorter, Vanessa P M van Empel, Olivier C Manintveld, Robert G Tieleman, Alexander H Maass, Kevin Vernooy, B Daan Westenbrink, Isabelle C van Gelder,[...]. Eur J Heart Fail 2020
17
18

Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients.
Aws Almufleh, Akshay S Desai, Renaud Fay, Joao Pedro Ferreira, Leo F Buckley, Mandeep R Mehra, Patrick Rossignol, Faiez Zannad. Eur J Heart Fail 2020
4
50

The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation.
Daniel Reichart, Daniel Kalbacher, Nicole Rübsamen, Eike Tigges, Christina Thomas, Johannes Schirmer, Hermann Reichenspurner, Stefan Blankenberg, Lenard Conradi, Ulrich Schäfer,[...]. Eur J Heart Fail 2020
36
18

Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort.
Jawad H Butt, Emil L Fosbøl, Thomas A Gerds, Charlotte Andersson, John J V McMurray, Mark C Petrie, Finn Gustafsson, Christian Madelaire, Søren Lund Kristensen, Gunnar H Gislason,[...]. Eur J Heart Fail 2020
31
18

Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Veli-Pekka Harjola, Wilfried Mullens, Marek Banaszewski, Johann Bauersachs, Hans-Peter Brunner-La Rocca, Ovidiu Chioncel, Sean P Collins, Wolfram Doehner, Gerasimos S Filippatos, Andreas J Flammer,[...]. Eur J Heart Fail 2017
167
18

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.
Thomas A Mavrakanas, Aisha Khattak, Karandeep Singh, David M Charytan. BMC Nephrol 2018
10
20

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Brendon L Neuen, Tamara Young, Hiddo J L Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Kenneth W Mahaffey, David M Charytan, David C Wheeler, Clare Arnott,[...]. Lancet Diabetes Endocrinol 2019
382
18

Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease.
Szu-Chia Chen, Ho-Ming Su, Chi-Chih Hung, Jer-Ming Chang, Wan-Chun Liu, Jer-Chia Tsai, Ming-Yen Lin, Shang-Jyh Hwang, Hung-Chun Chen. Clin J Am Soc Nephrol 2011
83
18

Left Ventricular Mass and Incident Chronic Kidney Disease.
Rajiv Agarwal, Rebecca J Song, Ramachandran S Vasan, Vanessa Xanthakis. Hypertension 2020
8
25

Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.
Hong-tao Shi, Xiao-jing Wang, Jun Li, Gui-fang Song, Zhe-yong Huang, Xiang-yu Guo, Jun-jie Guo, Zhi-yang Lv, Hong-wei Li, Jun-bo Ge,[...]. J Am Heart Assoc 2015
9
22

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.
Kevin Damman, Mattia A E Valente, Adriaan A Voors, Christopher M O'Connor, Dirk J van Veldhuisen, Hans L Hillege. Eur Heart J 2014
536
18

2018 ESC/ESH Guidelines for the management of arterial hypertension.
Bryan Williams, Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier, Denis L Clement, Antonio Coca, Giovanni de Simone, Anna Dominiczak,[...]. Eur Heart J 2018
18

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
18

Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.
Leila R Zelnick, Ronit Katz, Bessie A Young, Adolfo Correa, Bryan R Kestenbaum, Ian H de Boer, Nisha Bansal. Am J Kidney Dis 2017
10
20

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.
Josef Coresh, Hiddo J L Heerspink, Yingying Sang, Kunihiro Matsushita, Johan Arnlov, Brad C Astor, Corri Black, Nigel J Brunskill, Juan-Jesus Carrero, Harold I Feldman,[...]. Lancet Diabetes Endocrinol 2019
127
18


Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care.
Marco Trevisan, Edouard L Fu, Yang Xu, Gianluigi Savarese, Friedo W Dekker, Lars H Lund, Catherine M Clase, Arvid Sjölander, Juan J Carrero. Eur J Heart Fail 2021
17
18

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Janani Rangaswami, Vivek Bhalla, John E A Blair, Tara I Chang, Salvatore Costa, Krista L Lentine, Edgar V Lerma, Kenechukwu Mezue, Mark Molitch, Wilfried Mullens,[...]. Circulation 2019
375
18

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
18

Epidemiology of heart failure.
Amy Groenewegen, Frans H Rutten, Arend Mosterd, Arno W Hoes. Eur J Heart Fail 2020
394
18

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
David C Wheeler, Robert D Toto, Bergur V Stefánsson, Niels Jongs, Glenn M Chertow, Tom Greene, Fan Fan Hou, John J V McMurray, Roberto Pecoits-Filho, Ricardo Correa-Rotter,[...]. Kidney Int 2021
56
18

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Stefan D Anker, Javed Butler, Gerasimos Filippatos, João P Ferreira, Edimar Bocchi, Michael Böhm, Hans-Peter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure-Valenzuela,[...]. N Engl J Med 2021
847
18

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.
Scott D Solomon, Rudolf A de Boer, David DeMets, Adrian F Hernandez, Silvio E Inzucchi, Mikhail N Kosiborod, Carolyn S P Lam, Felipe Martinez, Sanjiv J Shah, Daniel Lindholm,[...]. Eur J Heart Fail 2021
98
18


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
18

Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.
Bettina J Kraus, Matthew R Weir, George L Bakris, Michaela Mattheus, David Z I Cherney, Naveed Sattar, Hiddo J L Heerspink, Ivana Ritter, Maximilian von Eynatten, Bernard Zinman,[...]. Kidney Int 2021
58
18

Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
C David Mazer, Gregory M T Hare, Philip W Connelly, Richard E Gilbert, Nadine Shehata, Adrian Quan, Hwee Teoh, Lawrence A Leiter, Bernard Zinman, Peter Jüni,[...]. Circulation 2020
142
18

Cardiovascular disease and subsequent kidney disease.
Essam F Elsayed, Hocine Tighiouart, John Griffith, Tobias Kurth, Andrew S Levey, Deeb Salem, Mark J Sarnak, Daniel E Weiner. Arch Intern Med 2007
182
18

Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease.
Maneesh Sud, Navdeep Tangri, Melania Pintilie, Andrew S Levey, David Naimark. Circulation 2014
46
18

ESRD and death after heart failure in CKD.
Maneesh Sud, Navdeep Tangri, Melania Pintilie, Andrew S Levey, David M J Naimark. J Am Soc Nephrol 2015
29
18

Clinical and subclinical cardiovascular disease and kidney function decline in the elderly.
Michael G Shlipak, Ronit Katz, Bryan Kestenbaum, Linda F Fried, David Siscovick, Mark J Sarnak. Atherosclerosis 2009
81
18

Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis.
Lesley A Inker, Andrew S Levey, Kruti Pandya, Nicholas Stoycheff, Aghogho Okparavero, Tom Greene. Am J Kidney Dis 2014
84
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.